Definium Therapeutics, Inc. Common Shares — Chart, Price & News (NASDAQ:DFTX)

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Market Capitalization 2.19 B
Employee 106
Founded 2010
CEO Robert Barrow
Website www.definiumtx.com
Headquarter British Columbia, Canada
FIGI BBG00F13HYQ7
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

2.19 B Market capitalization

Definium Therapeutics Inc

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.